Chaft, J. E., Weder, W., He, J., Chen, K., Hochmair, M., Shih, J., Lee, S. Y., Lee, K., Nhung, N., Saeteng, S., Teixeira, C. H. A., Escriu, C., Martinez-Marti, A., Blakely, C. M., Yatabe, Y., Dacic, S., Huang, X., Rukazenkov, Y., Dayal, A., Tsuboi, M. (2025). Neoadjuvant (neoadj) osimertinib (osi) ± chemotherapy (CT) vs CT alone in resectable (R) epidermal growth factor receptor-mutated (EGFRm) NSCLC: NeoADAURA.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.8001